was successfully added to your cart.

Your SEO optimized title page contents

Quantum 9 To Provide Consulting, Technology and Implementation to Canada-Based Vida Cannabis Corp.

In a move to expand its service base across North America, Quantum 9 signed on to provide consulting, technology and implementation services for Canada-based Vida Cannabis Corp. (Vida Cannabis) in April.

As the pre-eminent authority on cannabis cultivation and technology in North America, Quantum 9 will assist in finalizing Vida Cannabis’s MMPR application. Quantum 9’s extensive experience working with Health Canada has provide the framework for assisting in the administrative process of licensure applications. With the help of Quantum 9 Vida Cannabis has completed the initial submission to Health Canada. 

In addition, Quantum 9 will help design a state-of-the-art production facility that will be nearly twice the size of any currently licensed producer in Canada. Quantum 9 has been on location in Stellarton, Nova Scotia where Vida Cannabis has secured a 50-year irrevocable approval unanimously from the local municipality to operate a medical marijuana production plant. Personnel are in the process of finalizing the security and facility design to optimize the build-out of Vida's 315,000-square-foot facility, including an initial production area of approximately 30,000 square feet, with a roadmap for expansion driven by market demand.

Quantum 9’s Derek Ogden is helping to finalize and implement the minimum level-9 security plan, with some areas of the facility utilizing level 10 and 11 measures. The highly secure facility includes a fully engineered concrete floor, 18-foot-high concrete walls and a steel roof.

Quantum 9 CEO Michael Mayes stated: "We are very excited about our partnership with Vida Cannabis. Their executive staff rivals that of the best we have seen in the industry and we are excited to bring our expert experience to ensure a best-in-class operation."

Vida Cannabis is focused on developing its production footprint in the quickly growing global marketplace for legal medicinal and recreational marijuana. Initial operations will be focused on the Canadian market and will be looking to acquire commercial production licenses under Health Canada’s Marihuana for Medical Purposes Regulations – a distinction for best-in-class producers.

Vida Cannabis will continue to evaluate potential markets as regulatory bodies around the world pass legislation enabling the production and distribution of medicinal or recreational marijuana.

Canada opened its medical marijuana free market in October 2013, phasing out small operations for large-scale, standardized and certified operations. Health Canada has placed no limits on the number of facilities, but patients can only purchase from a single producer. Federal projections for the industry are around $1.3 billion by 2024.

About Michael Mayes

As Chief Executive Officer for Quantum 9, Inc., Michael has assisted in funding some of the largest commercial cannabis projects in the world. Michael has been a cannabis investor since 2009 in Colorado’s first legal for-profit cannabis market. As the co-founder and CEO of Quantum 9, Inc., Michael has spent years designing technology and collaborating with countless consultants on the forefront of the cannabis industry. Collaborating with the brightest minds and contributing to world-class organizations has been an incredibly enlightening and rewarding experience for him. Also, he has amassed a comprehensive and award-winning team engaged globally for public policy best practices through the prioritization of environmental sustainability and patient care. Michael is a member of the International Cannabinoid Research Society (ICRS), contributor to Marijuana Business Daily, quoted in the Chicago Tribune, Tampa Tribune, Yahoo Finance, Tampa Tribune, Sativa Magazine, CBC and the Daily Herald. His media appearances include several CBS and WGN appearances and international presence on BNN Commodities in Canada. On the public policy front, Michael and his team were instrumental in their work of drafting the Kentucky Medical Marijuana Bill for Senator Perry Clark. Most recently, Michael taught a class for the International Pharmaceutical Academy in Toronto, Canada. He spoke on Cannabis Pharmacology, and the effects cannabis has on the endocannabinoid system.

Leave a Reply